Yu Fan

Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$94.9M2026 Q3
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Yu Fan reported 6 positions worth $94.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: KMTS (68.0%). Biggest move: exit ALMS ($7.1M).

6 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 KMTSKestra Medical Technologies$64.6M68.03%2,282,519——-1.1%
▸ 2 WHWKWhitehawk Therapeutics$18.2M19.13%4,829,398———
▸ 3 IVAInventiva S.A.$5.5M5.83%1,500,000———
▸ 4 PMNProMIS Neurosciences$3.6M3.77%329,760——-69.5%
▸ 5 CATXPerspective Therapeutics$2.9M3.06%1,055,409——-66.4%
▸ 6American Bitc…American Bitcoin$174.2K0.18%20,538———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Yu Fan hold as of Q3 2026?

Yu Fan reported 6 positions worth $94.9M in its Q3 2026 13F filing. Largest positions: KMTS (68.0%), WHWK (19.1%), IVA (5.8%), PMN (3.8%) and CATX (3.1%).

What did Yu Fan buy in Q3 2026?

Yu Fan opened or added to no positions in Q3 2026.

What did Yu Fan sell in Q3 2026?

Reduced: AMERICAN BITCOIN CORP. and WHWK. Sold out entirely: ALMS and CBLL.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.